Alessandra Crippa

822 total citations · 1 hit paper
8 papers, 536 citations indexed

About

Alessandra Crippa is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Alessandra Crippa has authored 8 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Alessandra Crippa's work include Cancer-related Molecular Pathways (3 papers), Acute Myeloid Leukemia Research (2 papers) and RNA modifications and cancer (2 papers). Alessandra Crippa is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Acute Myeloid Leukemia Research (2 papers) and RNA modifications and cancer (2 papers). Alessandra Crippa collaborates with scholars based in Italy, United States and Sudan. Alessandra Crippa's co-authors include Joana A. Vidigal, Ciro Bonetti, Natasha Rekhtman, Andrea Ventura, Scott W. Lowe, Paul Ogrodowski, Eusebio Manchado, Danilo Maddalo, Carla P. Concepcion and Elisa de Stanchina and has published in prestigious journals such as Nature, Blood and International Journal of Molecular Sciences.

In The Last Decade

Alessandra Crippa

8 papers receiving 524 citations

Hit Papers

In vivo engineering of oncogenic chromosomal rearrangemen... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Crippa Italy 6 439 133 121 51 43 8 536
Wei Wen China 13 737 1.7× 198 1.5× 98 0.8× 64 1.3× 44 1.0× 18 803
Emma Haapaniemi Finland 4 829 1.9× 260 2.0× 146 1.2× 79 1.5× 42 1.0× 6 934
Phillip A. Doerfler United States 12 566 1.3× 272 2.0× 103 0.9× 31 0.6× 46 1.1× 20 770
Lin Ye United States 6 804 1.8× 297 2.2× 206 1.7× 70 1.4× 38 0.9× 8 912
Stamatis Papathanasiou United States 6 551 1.3× 144 1.1× 71 0.6× 42 0.8× 58 1.3× 6 666
Sandeep K. Botla Germany 5 912 2.1× 258 1.9× 176 1.5× 79 1.5× 42 1.0× 5 1.0k
Jordan Pinder Canada 12 597 1.4× 92 0.7× 100 0.8× 15 0.3× 60 1.4× 14 682
Ya-Wen Fu China 10 637 1.5× 190 1.4× 81 0.7× 58 1.1× 42 1.0× 15 709
Cameron Arakaki United States 6 417 0.9× 121 0.9× 44 0.4× 28 0.5× 28 0.7× 8 485
Carmencita E. Nicolas United States 2 684 1.6× 314 2.4× 133 1.1× 82 1.6× 18 0.4× 2 776

Countries citing papers authored by Alessandra Crippa

Since Specialization
Citations

This map shows the geographic impact of Alessandra Crippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Crippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Crippa more than expected).

Fields of papers citing papers by Alessandra Crippa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Crippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Crippa. The network helps show where Alessandra Crippa may publish in the future.

Co-authorship network of co-authors of Alessandra Crippa

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Crippa. A scholar is included among the top collaborators of Alessandra Crippa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Crippa. Alessandra Crippa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Villa, Federica, Alessandra Crippa, A Ardizzoia, et al.. (2023). Progression after First-Line Cyclin-Dependent Kinase 4/6 Inhibitor Treatment: Analysis of Molecular Mechanisms and Clinical Data. International Journal of Molecular Sciences. 24(19). 14427–14427. 5 indexed citations
2.
Messina, Carlo, Anna Candoni, Matteo Giovanni Carrabba, et al.. (2014). Wilms' Tumor Gene 1 Transcript Levels in Leukapheresis of Peripheral Blood Hematopoietic Cells Predict Relapse Risk in Patients Autografted for Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 20(10). 1586–1591. 26 indexed citations
3.
Maddalo, Danilo, Eusebio Manchado, Carla P. Concepcion, et al.. (2014). In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature. 516(7531). 423–427. 468 indexed citations breakdown →
4.
Toffalori, Cristina, Elisabetta Xue, Lara Crucitti, et al.. (2014). Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT. Blood. 124(21). 3951–3951. 1 indexed citations
5.
Bidoli, Paolo, Diego Cortinovis, Ilaria Colombo, et al.. (2010). Isotretinoin Plus Clindamycin Seem Highly Effective Against Severe Erlotinib-Induced Skin Rash in Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(10). 1662–1663. 18 indexed citations
6.
Lima, Júlio César de, et al.. (2006). Molecular analysis of the seedlessness character in grape using RAPD markers. Crop Breeding and Applied Biotechnology. 6(3). 209–214. 3 indexed citations
7.
Russo, Patrizia, et al.. (2002). Nonpeptidomimetic Farnesyltransferase Inhibitor RPR-115135 Increases Cytotoxicity of 5-Fluorouracil: Role of p53. Journal of Pharmacology and Experimental Therapeutics. 300(1). 220–226. 5 indexed citations
8.
Russo, Patrizia, et al.. (2001). RPR-115135, a new non peptidomimetic farnesyltransferase inhibitor, induces G0/G1 arrest only in serum starved cells. International Journal of Oncology. 18(4). 855–62. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026